Model-based comparison of maternal and foetal organ doses from 99mTc pertechnetate, DMSA, DTPA, HDP, MAA and MAG3 diagnostic intakes during pregnancy

European Journal of Nuclear Medicine

Volumn 29, Issue 10, 2002, Pages 1365-1373

  Saunders, Margaret ^a   Palmer, Maria ^a   Preece, Alan ^a   Millard, Roger ^a  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

Author keywords

Foetus; Organ dose; Pregnancy; Radiopharmaceuticals; Technetium 99m

Indexed keywords

MACROSALB TC 99M; MERTIATIDE TC 99M; OXIDRONATE TECHNETIUM TC 99M; PENTETATE TECHNETIUM TC 99M; PERTECHNETIC ACID TC 99M; SUCCIMER TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; ALBUMIN PENTETATE TECHNETIUM TC 99M; MACROSALB I 131; MELANOMA ANTIGEN 3; SUCCIMER;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DATA BASE; DOSE CALCULATION; DRUG DISTRIBUTION; FETUS; NONHUMAN; ORGAN DISTRIBUTION; PHANTOM; PLACENTAL TRANSFER; PREGNANCY; RADIATION DOSE; RADIOISOTOPE DIAGNOSIS; THYROID GLAND; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; CLASSIFICATION; COMPARATIVE STUDY; FEMALE; FETOMATERNAL TRANSFUSION; GUINEA PIG; HUMAN; METABOLISM; METHODOLOGY; RADIATION EXPOSURE; RADIOMETRY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STANDARD; TISSUE DISTRIBUTION; WHOLE BODY COUNTING; IN VIVO STUDY; INTERMETHOD COMPARISON; MATERNAL CARE; NEWBORN; THIRD TRIMESTER PREGNANCY;

ANIMALS; FEMALE; FETUS; GUINEA PIGS; HUMANS; MATERNAL-FETAL EXCHANGE; MODELS, BIOLOGICAL; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; PREGNANCY; PREGNANCY TRIMESTERS; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; SODIUM PERTECHNETATE TC 99M; TISSUE DISTRIBUTION; WHOLE-BODY COUNTING;

EID: 0036383480     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0858-6     Document Type: Article

References (22)

1. ICRP. Pregnancy and medical radiation. (ICRP Publication 84). Ann ICRP 2000; 30:1-39.
2. Reddy AR, Jain SC. Approaches to assessing doses to the embryo and fetus. Radiat Prot Dosim 1998; 79:289-298.
3. Stather JW, Phipps AW. The work of Committee 2 of ICRP in developing dose coefficients for the embryo and fetus. Radiat Prot Dosim 1998; 79:299-302.
4. NCRP. Radionuclide exposure of the embryo/fetus. (NCRP Report no. 128). Bethesda: National Council on Radiation Protection and Measurements, 1998.
5. Russell JR, Stabin MG, Sparks RB. Placental transfer of radiopharmaceuticals and dosimetry in pregnancy. Health Phys 1997; 73:747-755.
6. Russell JR, Stabin MG, Sparks RB, Watson EE. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys 1997; 73:756-769.
7. Stabin MG, Tagesson M, Thomas SR, Ljungberg M, Strand SE. Radiation dosimetry in nuclear medicine. Appl Radiat Isot 1999; 50:73-87.
8. Loevinger R, Budinger TF, Watson EE. MIRD primer for absorbed dose calculations. New York: The Society for Nuclear Medicine, 1991.
9. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37:538-546.
10. Stabin MG, Watson EE, Cristy M, et al. Mathematical models and specific absorbed fractions of photon energy in the non-pregnant adult female and at the end of each trimester of pregnancy. Report ORNL/TM-12907. Oak Ridge, Tenn.: Oak Ridge National Laboratory, 1995.
11. Palmer AM, Preece AW. Placenta transfer of technetium labelled radiopharmaceuticals in the guinea pig. J Nucl Med 1993; 35:159P.
12. Palmer AM, Preece AW. Placenta transfer of medical radionuclides in the guinea pig and the mouse. Radiat Prot Dosim 1998; 79:317-321.
13. Iwi G, Millard RK, Palmer AM, Preece AW, Saunders M. Bootstrap resampling: a powerful method of assessing confidence intervals for doses from experimental data. Phys Med Biol 1999; 44:N55-N62.
14. Roedler HD. Assessment of foetal activity concentration and foetal dose for selected radionuclides based on animal and human data. In: Gerber GB, Metivier H, Smith H, eds. Age-related factors in radionuclide metabolism and dosimetry. Dordrecht: Kluwer; 1987:327-338.
15. Sparks RB, Aydogan B. Comparison of the effectiveness of some common animal data scaling techniques in estimating human radiation dose. In: S-Stelson AT, Stabin MG, Sparks RB, eds. Sixth International Radio-pharmaceutical Dosimetry Symposium. Oak Ridge, Tenn.: Associated Universities; 1999:705-716.
16. Naylor GPL, Ellender M, Harrison JD. The interpretation of animal data in the calculation of doses from new radiolabelled compounds. In: Watson EE, Schlafke-Stelson AT, eds. Fifth International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, Tenn.: Associated Universities; 1992:52-56.
17. Roedler HD. Accuracy of internal dose calculations with special consideration of radiopharmaceutical biokinetics. In: Watson EE, Schlafke-Stelson AT, Coffey JL, Cloutier RJ, eds. Third International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, Tenn.: Associated Universities; 1980: 1-20.
18. Millard RK, Saunders M, Palmer AM, Preece AW. Approximate distribution of dose among foetal organs for radioiodine uptake via placenta transfer. Phys Med Biol 2001; 46:2773-2783.
19. ICRP. Limits for intakes of radionuclides by workers. (ICRP Publication 30, part 2). Ann ICRP 1980; 4.
20. ICRP. Radiation dose to patients from radiopharmaceuticals. (ICRP Publication 53). Ann ICRP 1987; 18 (1-4).
21. ICRP. Doses to the embryo and fetus from intakes of radionuclides by the mother. (Publication 88). Ann ICRP 2001; 31(1-3).
22. Ulanovsky AV, Eckerman KF. Absorbed fractions for electron and photon emissions in the developing thyroid: fetus to five years old. Radiat Prot Dosim 1998; 79:419-424.